Carperitide

N/A

Report date: 2026/03/12 10:28:39

Base Information

Drug NameCarperitide
Drug Alias Name卡培立肽Human atrial natriuretic peptideCarperitidaCarperitidumHANP +[13
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsHeart FailureCardiomyopathiesRespiratory Distress Syndrome, Adult
Global Approved IndicationsHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1995/01/20
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesSuntory Pharmaceutical
Active IndicationsHeart Failure
Inactive IndicationsCardiomyopathiesRespiratory Distress Syndrome, Adult

Other Information

ATC CodeC01DX
Related LinksWikipediaKEGG